University of Cambridge > > Sensors CDT seminars > Biological drug development in Biotech and Big Pharma

Biological drug development in Biotech and Big Pharma

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Suzanne Boone.

This talk will give an overview of the development of biological medicines with a focus on monoclonal antibody R&D from 25 years ago to the present. This will include consideration of the importance of measurement and resultant understanding of the complex systems used for manufacturing biologic drugs so that they ultimately can benefit patients. The talk will be from an industrial scientist’s from both a Biotech. and “Big Pharma” perspective. It will consider the importance of vision with “the end in mind” to drive the science and innovation that has enabled the huge success of this class of medicine. Looking to the future the talk will also touch on the response to the pandemic and how that has the potential to transform development in the future.

This talk is part of the Sensors CDT seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity